Greenberg PL - Search Results

1

Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis.

Komrokji RS, Platzbecker U, Fenaux P, Zeidan AM, Garcia-Manero G, Mufti GJ, Santini V, Díez-Campelo M, Finelli C, Jurcic JG, Greenberg PL, Sekeres MA, DeZern AE, Savona MR, Shetty JK, Ito R, Zhang G, Ha X, Backstrom JT, Verma A. Komrokji RS, et al. Among authors: greenberg pl. Leukemia. 2022 May;36(5):1432-1435. doi: 10.1038/s41375-022-01521-4. Epub 2022 Feb 26. Leukemia. 2022. PMID: 35220402 Free PMC article. No abstract available.

2

Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes.

Nagler A, Ginzton N, Negrin R, Bang D, Donlon T, Greenberg P. Nagler A, et al. Leukemia. 1990 Mar;4(3):193-202. Leukemia. 1990. PMID: 1690318

3

Effects of granulocyte colony-stimulating factor therapy on in vitro hemopoiesis in myelodysplastic syndromes.

Nagler A, MacKichan ML, Negrin RS, Donlon T, Greenberg PL. Nagler A, et al. Among authors: greenberg pl. Leukemia. 1995 Jan;9(1):30-9. Leukemia. 1995. PMID: 7531261

4

International scoring system for evaluating prognosis in myelodysplastic syndromes.

Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J. Greenberg P, et al. Blood. 1997 Mar 15;89(6):2079-88. Blood. 1997. PMID: 9058730 Free article.

5

Bcl-2 expression by myeloid precursors in myelodysplastic syndromes: relation to disease progression.

Davis RE, Greenberg PL. Davis RE, et al. Among authors: greenberg pl. Leuk Res. 1998 Sep;22(9):767-77. doi: 10.1016/s0145-2126(98)00051-4. Leuk Res. 1998. PMID: 9716007 Free article.

6

Risk factors and their relationship to prognosis in myelodysplastic syndromes.

Greenberg PL. Greenberg PL. Leuk Res. 1998 May;22 Suppl 1:S3-6. doi: 10.1016/s0145-2126(98)00040-x. Leuk Res. 1998. PMID: 9734692 Review.

7

Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatment.

Greenberg PL. Greenberg PL. Leuk Res. 1998 Dec;22(12):1123-36. doi: 10.1016/s0145-2126(98)00112-x. Leuk Res. 1998. PMID: 9922076 Free article. Review.

8

Myelodysplastic syndromes.

Greenberg PL, Young NS, Gattermann N. Greenberg PL, et al. Hematology Am Soc Hematol Educ Program. 2002:136-61. doi: 10.1182/asheducation-2002.1.136. Hematology Am Soc Hematol Educ Program. 2002. PMID: 12446422 Review.

9

Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes.

List A, Beran M, DiPersio J, Slack J, Vey N, Rosenfeld CS, Greenberg P. List A, et al. Leukemia. 2003 Aug;17(8):1499-507. doi: 10.1038/sj.leu.2403021. Leukemia. 2003. PMID: 12886236 Review.

10

Myelodysplastic syndromes.

Greenberg PL, Attar E, Battiwalla M, Bennett JM, Bloomfield CD, DeCastro CM, Deeg HJ, Erba HP, Foran JM, Garcia-Manero G, Gore SD, Head D, Maness LJ, Millenson M, Nimer SD, O'Donnell MR, Saba HI, Shami PJ, Spiers K, Stone RM, Tallman MS, Westervelt P; NCCN Myelodysplastic Syndromes Panel. Greenberg PL, et al. J Natl Compr Canc Netw. 2008 Oct;6(9):902-26. J Natl Compr Canc Netw. 2008. PMID: 18926100 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

231 results

Search Page